These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5445741)

  • 1. Parmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man.
    Levy G; O'Reilly RA; Aggeler PM; Keech GM
    Clin Pharmacol Ther; 1970; 11(3):372-7. PubMed ID: 5445741
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics of the anticoagulant effect of bishydroxycoumarin in man.
    O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1970; 11(3):378-84. PubMed ID: 4192280
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of pharmacologic effects in man: the anticoagulant action of warfarin.
    Nagashima R; O'Reilly RA; Levy G
    Clin Pharmacol Ther; 1969; 10(1):22-35. PubMed ID: 5765183
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.
    O'Reilly RA; Levy G
    J Pharm Sci; 1970 Sep; 59(9):1258-61. PubMed ID: 5469787
    [No Abstract]   [Full Text] [Related]  

  • 5. Kinetics of anticoagulant effect of dicumarol in rats.
    Wingard LB; Levy G
    J Pharmacol Exp Ther; 1973 Jan; 184(1):253-60. PubMed ID: 4119618
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the interaction of warfarin and clofibrate in man.
    O'Reilly RA; Sahud MA; Robinson AJ
    Thromb Diath Haemorrh; 1972 Apr; 27(2):309-18. PubMed ID: 4340370
    [No Abstract]   [Full Text] [Related]  

  • 7. Potentiation of anticoagulant effect of warfarin by phenylbutazone.
    Aggeler PM; O'Reilly RA; Leong L; Kowitz PE
    N Engl J Med; 1967 Mar; 276(9):496-501. PubMed ID: 6018280
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin.
    Yacobi A; Wingard LB; Levy G
    J Pharm Sci; 1974 Jun; 63(6):868-72. PubMed ID: 4851098
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticoagulant activity of some selected warfarin analogues.
    Obaseki AO; Coker HB
    J Pharm Pharmacol; 1987 Feb; 39(2):142-4. PubMed ID: 2882003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral anticoagulants--the totem and the taboo.
    Breckenridge A
    Br Med J; 1976 Feb; 1(6007):419-23. PubMed ID: 766893
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of influenza vaccine on warfarin anticoagulation.
    Kramer P; Tsuru M; Cook CE; McClain CJ; Holtzman JL
    Clin Pharmacol Ther; 1984 Mar; 35(3):416-8. PubMed ID: 6697649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K and oral anticoagulant drugs as competitive antagonists in man.
    O'Reilly RA
    Pharmacology; 1972; 7(3):149-58. PubMed ID: 5054585
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of drug action in man.
    Levy G
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():203-10. PubMed ID: 5316402
    [No Abstract]   [Full Text] [Related]  

  • 17. Procoagulant effect of phenobarbital in rats.
    Yacobi A; Slattery JT; Levy G
    Life Sci; 1980 Apr; 26(17):1379-83. PubMed ID: 7382722
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant resistance: an unusual case.
    Barnett DB; Hancock BW
    Br Med J; 1975 Mar; 1(5958):608-9. PubMed ID: 1125626
    [No Abstract]   [Full Text] [Related]  

  • 19. The plasma half lives and the pharmacological effect of the enantiomers of warfarin in rats.
    Breckenridge A; Orme ML
    Life Sci II; 1972 Apr; 11(7):337-45. PubMed ID: 4656510
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the bioavailabilities and anticoagulant activities of two warfarin formulations.
    Stirling Y; Howarth DJ; Stockley R; Bland R; Towler CM; Harding SM
    Br J Haematol; 1982 May; 51(1):37-46. PubMed ID: 7073989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.